Simvastatin Outperforms Melatonin in Early Alveolar Bone Regeneration Following Mandibular Third Molar Extraction: A...

Area of Science:

• Oral Surgery
• Regenerative Medicine
• Pharmacology

Background:

• Mandibular third molar extraction often leads to complications like delayed healing and bone loss.
• Alveolar bone regeneration and effective pain management are crucial for postoperative recovery.
• Investigating novel therapeutic agents for socket preservation is of clinical interest.

Purpose of the Study:

• To compare the efficacy of simvastatin versus melatonin in promoting alveolar bone regeneration.
• To assess the impact of simvastatin and melatonin on postoperative pain and soft tissue healing.
• To evaluate the clinical utility of these agents in mandibular third molar extraction sockets.

Main Methods:

• A prospective, randomized, split-mouth, single-blinded clinical study.
• Thirty patients received simvastatin (10 mg) on one side and melatonin (3 mg) on the other, delivered via gelatin sponge.
• Evaluations included pain (VAS), soft tissue healing (Landry's Index), and bone regeneration (radiographic histogram analysis) over 12 weeks.

Main Results:

• Simvastatin treatment showed significantly higher bone regeneration (grayscale values) at 1 and 4 weeks post-extraction (P < 0.001 and P = 0.009, respectively).
• Simvastatin significantly reduced postoperative pain at week 1 (P = 0.004) compared to melatonin.
• No significant differences in soft tissue healing were observed between the two agents.

Conclusions:

• Simvastatin exhibits superior early osteogenic potential and analgesic effects compared to melatonin in mandibular third molar extraction sockets.
• The accessibility and cost-effectiveness of simvastatin suggest its potential as a valuable agent for socket preservation.
• Further research may explore long-term outcomes and optimal application protocols for simvastatin in oral surgery.